There are many randomized controlled trials relating to stroke rehabilitation being carried out in China, which are often published in Chinese-language journals. A recent update to our Cochrane systematic review of physical rehabilitation to improve function and mobility after stroke included 96 trials; over half (51) were conducted in China; 37 of these included studies were published in Chinese. Analyses within this Cochrane review support the conclusion that physical rehabilitation, using a mix of components from different approaches, is effective for the recovery of function and mobility after stroke. The inclusion of the Chinese studies had a substantial impact on the volume of evidence and, consequently, the conclusions. In this paper, we explore whether it is appropriate to draw implications for clinical practice throughout the world from evidence relating to a complex rehabilitation intervention delivered within one particular geographical healthcare setting. We explore the unique challenges associated with incorporating the body of evidence from China, particularly the Chinese-language publications, and identify the ongoing debate about the quality of Chinese research publications. We conclude that the growing body of evidence from China has important implications for future systematic reviews and evidence-based stroke care, but analysis and interpretation raise challenges, and improved reporting is critical.
The rapidly growing number of randomized controlled trials (RCTs) published in Chinese provides a valuable resource for systematic reviews (1), contributing potentially important evidence to inform stroke rehabilitation (2) . A recent update to our Cochrane systematic review of physical rehabilitation after stroke included 96 trials; over half (51) were conducted in China, with 37 published in the Chinese language (3) . The inclusion of these international studies had a substantial impact on the volume of evidence and, consequently, the conclusions. However, it is pertinent to explore whether evidence relating to a complex rehabilitation intervention delivered within one healthcare setting, with accompanying cultures and beliefs associated with health and disease, can have implications for clinical practice in other settings throughout the world.
Our review sought to determine the relative effectiveness of different physical rehabilitation approaches aimed at improving functional independence (in activities of daily living, ADL) and motor recovery (function) after stroke (4) . The previous version of the review (4) highlighted a growing body of potentially relevant international evidence. For the current review, we convened a stakeholder group of stroke survivors, carers, and physiotherapists specifically to explore whether it was clinically meaningful to bring this body of international evidence together. We used nominal group techniques to reach consensus decisions (5) around the clinical relevance of synthesizing international trials of different physical rehabilitation approaches within the Cochrane review. These stakeholders unanimously agreed that all international evidence relating to physical rehabilitation approaches should be integrated into the updated review.
This decision resulted in the inclusion of 51 trials carried out in China (59 in total from Asia). Figure 1 illustrates the geographical location of the 96 included trials. Data from 27 RCTs (3423 participants) comparing physical rehabilitation with no treatment were pooled for the independence in ADL outcome and from 25 RCTs (4558 participants) relating to the motor function outcome. Almost all of this evidence came from China: 25 RCTs (3173 participants) and 23 RCTs (4308 participants), respectively. These pooled analyses demonstrated that physical rehabilitation has a significantly beneficial effect as compared with no intervention on independence in ADL [standardized mean difference (SMD) 0·78, 95% CI (0·58, 0·97)] and motor function [SMD 0·81, 95% CI (0·58, 1·04)]. Analysis of available follow-up data provided some evidence that the benefits were maintained beyond the end of the intervention [9 studies, 540 participants, SMD 0·58, 95% CI (0·11, 1·04) for independence in ADL, of which 7 studies, 308 participants, were from China; 8 studies, 1829 participants, SMD 1·06, 95% CI (0·37, 1·75) for motor function, of which 6 studies, 1595 participants, were from China].
Together with the results of analyses from other comparisons in this Cochrane review, these data suggest that physical rehabilitation, using a mix of components from different approaches, is effective for the recovery of function and mobility after stroke.
However, many of the Chinese RCTs compared physical rehabilitation approaches with no treatment. Therefore, some of the challenges to interpretation of these findings relate to whether it is appropriate to draw implications from this Chinese evidence to settings where no treatment may be considered unethical. Arguably, this evidence potentially has few direct implications for settings other than those where standard care comprises no physical rehabilitation. Yet the potential value of this evidence to other international contexts may lie in the indirect implications relating to issues such as dose, content, and timing of interventions.
Incorporating the body of evidence from China, particularly the Chinese-language publications, provided a number of challenges. These included the resources required for translation of Chinese-language publications and the complexity of interpreting data arising from different healthcare systems and cultures. We also experienced difficulties in searching and accessing papers published in some Chinese journals, with the British Library reporting that they were unable to locate some of the identified papers. The methods we used to assess the Chinese-language publications were arguably less robust than those we used for English-language publications, as -while all English-language publications were assessed independently by two reviewers -we relied on translations by the one member of our team who spoke Chinese. Similar limitations have also been described in a systematic review of Chinese trials of stroke rehabilitation (2) .
In addition to these practical problems associated with identifying, assessing, and synthesizing evidence from China, there is an ongoing debate about the quality of Chinese research publications, which is associated with reports of high levels of plagiarism and data fabrication (6, 7) . It has been argued that within Chinese academic institutions there is a culture of rewarding researchers according to the number of publications, while failing to judge publication quality (8) . Such criticisms challenge the risk of bias associated with the inclusion of Chinese trials, but others argue that this problem is not limited to China. A systematic exploration of publication retractions found that more retractions, due to fraud or suspected fraud, occurred with research from the United States, Germany, and Japan than China, although China was found to have the greatest number of retractions due to duplicate publication (9) .
Within our Cochrane review, we conclude that our results are limited by poor reporting and substantial heterogeneity across the included trials. However, if we explore in more detail our judgment of risk of bias relative to the geographical location of the trial, we do observe a difference between the 59 studies carried out in Asia and those carried out in the rest of the world (Fig. 2) . The reporting of methodological details relating to randomization and allocation concealment was poorer in the studies from Asia; but conversely issues related to baseline differences appear better reported in these studies. From this we can only draw conclusions 
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A. Pollock et al. relating to the quality of reporting. There is clearly an urgent need for improvements in the quality of reporting of methodological details of rehabilitation trials across the whole world; but particularly in those trials from China. We therefore urge authors and journal editors to adhere to the CONSORT 2010 guidelines for the reporting of RCTs, facilitating complete and transparent reporting, and aiding their critical appraisal and interpretation (10, 11) .
In summary, our experience shows that there are many RCTs relating to stroke being carried out in China, which are often published in Chinese-language journals. The growing body of evidence clearly has important implications for future systematic reviews and evidence-based stroke care, but analysis and interpretation raise challenges, and improved reporting is critical.
